Eight years of qualification
Audited Supplier
In This Store
![N-[4-Bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide](https://eimg.pharmasources.com/image/20240603/GJG9EqFz7a8gG0nkorKuWjjAcPjVxmDlegrsopYB.png!280)
![Diethyl-2-acetamido-2-(7-chloro-5-(2-fluorophenyl)-3H- benzo[e][1,4]diazepin-2-yl)malonate](https://eimg.pharmasources.com/image/20240603/kCK1tVKXvO7mdpLTBNii5x61NUulXBiqHBf6clcn.png!280)
Sunasia Co., Ltd. was founded in 2002 and is headquartered in Ningbo, Zhejiang Province. The company is a comprehensive international pharmaceutical company specializing in R&D, production and sales of APIs and intermediates, and is a member of Ningbo Pharmaceutical Industry Association.
For more than twenty years, our portfolio has been based on the production and trade of active pharmaceutical ingredients, intermediates, nutraceuticals, veterinary products and speciality chemicals.
Year of Establishment: 2002
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 50-100
Main Competitive Advantages: Brand Name,International Approvals/Standards,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us：
Pharma Sources Insight January 2025
![N-[4-Bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide](https://eimg.pharmasources.com/image/20240603/GJG9EqFz7a8gG0nkorKuWjjAcPjVxmDlegrsopYB.png!200)
![Diethyl-2-acetamido-2-(7-chloro-5-(2-fluorophenyl)-3H- benzo[e][1,4]diazepin-2-yl)malonate](https://eimg.pharmasources.com/image/20240603/kCK1tVKXvO7mdpLTBNii5x61NUulXBiqHBf6clcn.png!200)
